Maaxmus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.00 M
- Revenue Growth 15.88%
- Profit Growth 10.91%
- Ebitda -9.70%
- Net Worth 32.06%
- Total Assets 1.69%
About Maaxmus Life Sciences
Maaxmus Life Sciences Private Limited (MLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 October 2018 (Six years and four months 0 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹6.00 M.
Chidambaram Senthilkumar, Saravanakumar Muthuramalingam, Pradeepraj Raj, and One other member serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909TN2018PTC125298
-
Company No.
125298
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Oct 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Maaxmus Life Sciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chidambaram Senthilkumar
|
Director | 16-Oct-2018 | Current |
|
Saravanakumar Muthuramalingam
|
Director | 16-Oct-2018 | Current |
|
Pradeepraj Raj
|
Director | 17-Sep-2020 | Current |
|
Omkirubaraj
|
Director | 24-May-2024 | Current |
Financial Performance of Maaxmus Life Sciences.
Maaxmus Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.88% increase. The company also saw a substantial improvement in profitability, with a 10.91% increase in profit. The company's net worth Soared by an impressive increase of 32.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maaxmus Life Sciences?
In 2023, Maaxmus Life Sciences had a public holding of 66.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Hywel Healthcare LlpChidambaram Senthilkumar is a mutual person
Charges (Loans)
₹6.00 M
₹0
Charges Breakdown by Lending Institutions
- Tamilnad Mercantile Bank Limited : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2018 | Tamilnad Mercantile Bank Limited | ₹6.00 M | Open |
How Many Employees Work at Maaxmus Life Sciences?
Maaxmus Life Sciences has a workforce of 17 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maaxmus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maaxmus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
